Evidence map›Paper›PMID 40296249›Full record

ArticleNeuropsychopharmacology reports2025

Exploring Secondary Mania: A Case of Medial Frontal Meningioma With Exceptional Response to Antimanic Medication.

Yu-Chih Shen, Hsiao-Yuan Su

Abstract readCase Reports
In one paragraph

Article in Neuropsychopharmacology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yu-Chih ShenDepartment of Psychiatry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.ORCID https://orcid.org/0000-0002-3503-5778
Hsiao-Yuan SuDepartment of Psychiatry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.ORCID https://orcid.org/0000-0002-5395-2414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mania is typically associated with psychiatric disorders but can also be secondary to other conditions, such as brain tumors. A notably rapid response to antimanic treatment suggests secondary mania. However, identifying such cases can be challenging. Mrs. M., a 52-year-old woman with a history of anxiety and dysthymia, presented with her first manic episode, marked by elevated mood, agitation, reduced sleep, racing thoughts, and grandiose delusions. Her manic symptoms emerged outside the usual age range for mania. She responded remarkably quickly to antimanic medication. Furthermore, her Young Mania Rating Scale (YMRS) score decreased from 36 to 6 within 3 days. This unusual response prompted further investigation, revealing a 46 mm enhancing mass in the medial frontal lobe, affecting the anterior cingulate cortex (ACC). This was confirmed as a meningioma upon surgical removal. The rapid treatment response, combined with the atypical age of onset, raised the suspicion of secondary mania. The discovery of a medial frontal meningioma and its subsequent surgical removal supported this diagnosis. Given the ACC's role in emotional regulation, its involvement likely contributed to the manic symptoms. A swift response to antimanic treatment can indicate secondary mania, such as that caused by a brain tumor. This case highlights the importance of considering secondary causes when mania presents atypically or responds unusually well to treatment.

Indexed as

Antimanic AgentsBipolar DisorderFrontal LobeManiaMeningeal NeoplasmsMeningiomaFemaleHumansMiddle AgedAntimanic Agentsanterior cingulate cortexbipolar disordermeningiomapsychopharmacologysecondary mania

Identifiers

PMID40296249
PMCPMC12037416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.